Zkusit zdarma
Anavex Life Sciences Corp.

Anavex Life Sciences Corp.

AVXL
Cena:
$ 2.70
-0.02 (-0.74%)
Valuace
70
Růst
30
Zdraví
50
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer

Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer

7:00 06-05-2026

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Compan...

Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease

Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease

7:30 14-04-2026

Findings underpin the scientific rationale for Anavex's targeted autophagy approach with orally admi...

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

7:30 07-04-2026

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Comp...

Anavex Life Sciences Provides Comprehensive Regulatory Update

Anavex Life Sciences Provides Comprehensive Regulatory Update

7:30 30-03-2026

Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral b...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

22:02 26-03-2026

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor...

Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback

Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback

10:40 25-03-2026

This decision follows feedback from the European Medicines Agency's (EMA) Committee for Medicinal Pr...

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease

7:30 25-03-2026

NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Comp...

Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer's Disease

Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer's Disease

7:30 23-03-2026

New data show brain-volume preservation correlates with patient outcomes Long-term clinical data ind...

New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer's Disease

New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer's Disease

7:30 20-03-2026

Findings underpin potential of Anavex' lead candidate blarcamesine through its upstream mechanism of...

Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson's Disease at AD/PD 2026 Conference

Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson's Disease at AD/PD 2026 Conference

7:30 17-03-2026

New data show that blarcamesine completely rescued impaired motor function Biomarker of nerve fiber ...

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

7:30 23-02-2026

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Compa...

Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know

Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know

13:02 12-02-2026

Anavex Life Sciences (AVXL) might move higher on growing optimism about its earnings prospects, whic...

Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?

Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?

10:41 12-02-2026

Here is how Anavex Life Sciences (AVXL) and Cabaletta Bio, Inc. (CABA) have performed compared to th...

Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript

Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript

11:14 09-02-2026

Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript...

Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update

7:30 09-02-2026

Company to host a  webcast today at 8:30 am Eastern Time...

Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026

Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026

7:30 03-02-2026

Webcast and Conference Call To be Held Monday, February 9, 2026, 8:30 am ET Webcast and Conference C...

Anavex Life Sciences Highlights Oral Alzheimer’s Drug Blarcamesine, Precision Strategy at JPM Conference

Anavex Life Sciences Highlights Oral Alzheimer’s Drug Blarcamesine, Precision Strategy at JPM Conference

4:06 15-01-2026

Anavex Life Sciences (NASDAQ: AVXL) outlined its strategy to develop oral, precision-medicine therap...

Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

22:15 14-01-2026

Anavex Life Sciences Corp. (AVXL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcri...

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer's Disease

7:30 13-01-2026

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Compa...

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm

20:13 08-01-2026

NEWTOWN, Pa., Jan. 8, 2026 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violatio...

close

ANAVEX LIFE SCIENCES REPORTS FISCAL 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

09-02-2026
COMPANY TO HOST A  WEBCAST TODAY AT 8:30 AM EASTERN TIME...
Více zde

ANAVEX LIFE SCIENCES TO ANNOUNCE FISCAL 2026 FIRST QUARTER FINANCIAL RESULTS ON MONDAY, FEBRUARY 9, 2026

03-02-2026
WEBCAST AND CONFERENCE CALL TO BE HELD MONDAY, FEBRUARY 9, 2026, 8:30 AM ET WEBCAST AND CONFERENCE C...
Více zde

ANAVEX JOINS ACCESS-AD, A MAJOR INITIATIVE FUNDED BY THE EUROPEAN COMMISSION, THROUGH THE CLINICAL EVALUATION OF BLARCAMESINE AS PART OF A PRECISION MEDICINE APPROACH IN ALZHEIMER'S DISEASE

13-01-2026
NEW YORK, JAN. 13, 2026 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

INVESTIGATION ALERT: EDELSON LECHTZIN LLP ANNOUNCES AN INVESTIGATION OF ANAVEX LIFE SCIENCES CORP. (NASDAQ: AVXL) AND ENCOURAGES INVESTORS WITH SUBSTANTIAL LOSSES CONTACT THE FIRM

08-01-2026
NEWTOWN, PA., JAN. 8, 2026 /PRNEWSWIRE/ -- EDELSON LECHTZIN LLP IS INVESTIGATING POTENTIAL VIOLATIO...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ANAVEX LIFE SCIENCES CORP. - AVXL

08-01-2026
NEW YORK, JAN. 8, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS ...
Více zde

ANAVEX LIFE SCIENCES APPOINTS SENIOR VICE PRESIDENT GLOBAL HEAD OF NEUROLOGY

08-01-2026
NEW YORK, JAN. 08, 2026 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ANAVEX LIFE SCIENCES CORP. – AVXL

06-01-2026
NEW YORK, JAN. 06, 2026 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

ANAVEX LIFE SCIENCES RECEIVES FDA FEEDBACK ON ALZHEIMER'S DISEASE PROGRAM

06-01-2026
NEW YORK, JAN. 06, 2026 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ANAVEX LIFE SCIENCES CORP. - AVXL

01-01-2026
NEW YORK, JAN. 1, 2026 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS ...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ANAVEX LIFE SCIENCES CORP. - AVXL

30-12-2025
NEW YORK, DEC. 30, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

AVXL INVESTORS HAVE OPPORTUNITY TO JOIN ANAVEX LIFE SCIENCES CORP. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

24-12-2025
LOS ANGELES, DEC. 24, 2025 (GLOBE NEWSWIRE) -- THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LI...
Více zde

ANAVEX LIFE SCIENCES SUBMITTED REQUEST FOR EMA TO RE-EXAMINE ITS OPINION

18-12-2025
NEW YORK, DEC. 18, 2025 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

ANAVEX LIFE SCIENCES PROVIDES UPDATE ON REGULATORY REVIEW IN THE EU FOR BLARCAMESINE TO TREAT EARLY ALZHEIMER'S DISEASE

12-12-2025
NEW YORK, DEC. 12, 2025 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ANAVEX LIFE SCIENCES CORP. - AVXL

11-12-2025
NEW YORK , DEC. 11, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

AVXL INVESTORS HAVE OPPORTUNITY TO JOIN ANAVEX LIFE SCIENCES CORP. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

10-12-2025
LOS ANGELES, DEC. 10, 2025 (GLOBE NEWSWIRE) -- THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LI...
Více zde

AVXL INVESTORS HAVE OPPORTUNITY TO JOIN ANAVEX LIFE SCIENCES CORP. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

03-12-2025
LOS ANGELES--(BUSINESS WIRE)---- $AVXL--AVXL INVESTORS HAVE OPPORTUNITY TO JOIN ANAVEX LIFE SCIENCES...
Více zde

ANAVEX LIFE SCIENCES TO PRESENT ORAL BLARCAMESINE DATA AT THE 18TH CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE

26-11-2025
NEW YORK, NOV. 26, 2025 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

ANAVEX LIFE SCIENCES REPORTS FISCAL 2025 FOURTH QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

25-11-2025
COMPANY TO HOST A WEBCAST T ODAY AT 8:30 A.M. EASTERN TIME...
Více zde

ANAVEX LIFE SCIENCES TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

19-11-2025
NEW YORK, NOV. 19, 2025 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ANAVEX LIFE SCIENCES CORP. - AVXL

18-11-2025
NEW YORK , NOV. 18, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

ANAVEX LIFE SCIENCES TO ANNOUNCE FISCAL 2025 FOURTH QUARTER FINANCIAL RESULTS ON TUESDAY, NOVEMBER 25, 2025

18-11-2025
WEBCAST AND CONFERENCE CALL TO BE HELD TUESDAY, NOVEMBER 25, 2025, 8:30 AM ET WEBCAST AND CONFERENCE...
Více zde

ANAVEX LIFE SCIENCES PROVIDES REGULATORY UPDATE ON BLARCAMESINE FOR EARLY ALZHEIMER'S DISEASE

14-11-2025
COMPANY PLANS TO REQUEST RE-EXAMINATION AFTER CHMP OPINION FEEDBACK FOLLOWING ITS ORAL EXPLANATION F...
Více zde

ANAVEX LIFE SCIENCES ANNOUNCES CONTINUED LONG-TERM BENEFIT FROM ORAL BLARCAMESINE COMPARED TO DECLINE OBSERVED IN THE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) CONTROL GROUP

29-10-2025
ADAS-COG13 DIFFERENCE −12.78 (P < 0.0001) WITH ORAL BLARCAMESINE TREATMENT COMPARED TO ADNI CONTRO...
Více zde

ANAVEX LIFE SCIENCES ANNOUNCES PRESENTATION AT THE 35TH ALZHEIMER EUROPE CONFERENCE ‘CONNECTING SCIENCE AND COMMUNITIES: THE FUTURE OF DEMENTIA CARE'

10-10-2025
PRESENTATION TITLE: “ADVANCING ALZHEIMER'S DISEASE CARE: CONVENIENCE FOR BOTH PATIENTS AND FAMILIE...
Více zde

ANAVEX LIFE SCIENCES ANNOUNCES SUCCESSFUL DEVELOPMENT OF ONCE-DAILY ORAL TABLET FORMULATION FOR THE ANAVEX®3-71 PROGRAM

02-10-2025
ANAVEX3-71-002 TRIAL ACHIEVED ITS PRIMARY ENDPOINT DEMONSTRATING SAFETY AND TOLERABILITY IN BOTH MAL...
Více zde

ANAVEX LIFE SCIENCES ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2 STUDY OF ANAVEX®3-71 FOR THE TREATMENT OF SCHIZOPHRENIA

02-10-2025
ANAVEX3-71-SZ-001 ACHIEVED ITS PRIMARY ENDPOINT DEMONSTRATING SAFETY AND TOLERABILITY IN ADULTS WITH...
Více zde

ANAVEX LIFE SCIENCES ANNOUNCES PUBLICATION OF ORAL BLARCAMESINE DESCRIBING A NEW CLASS OF CLINICAL PRECISION MEDICINE FROM PHASE IIB/III ALZHEIMER'S DISEASE TRIAL

30-09-2025
PUBLICATION TITLE: “ORAL BLARCAMESINE PHASE IIB/III TRIAL CONFIRMS IDENTIFIED PRECISION MEDICINE P...
Více zde

ANAVEX LIFE SCIENCES ANNOUNCES ORAL BLARCAMESINE COGNITIVE RESILIENCE RESULTS APPROXIMATING NORMAL AGING IN NEW PRECISION MEDICINE CLINICAL DATA FROM PHASE IIB/III ALZHEIMER'S DISEASE TRIAL

09-09-2025
NEW CLINICAL PRECISION MEDICINE POPULATION 48-WEEK DATA DEMONSTRATES UNPRECEDENTED COGNITIVE STABILI...
Více zde

ANAVEX LIFE SCIENCES TO PRESENT AT THE H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE 2025

02-09-2025
NEW YORK, SEPT. 02, 2025 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMP...
Více zde

ANAVEX LIFE SCIENCES REPORTS NEW PUBLICATION IN MEDICAL JOURNAL HIGHLIGHTING THE ESTABLISHED PRECISE AUTOPHAGY MECHANISM WITH BLARCAMESINE

26-08-2025
NEW YORK, AUG. 26, 2025 (GLOBE NEWSWIRE) -- ANAVEX LIFE SCIENCES CORP. (“ANAVEX” OR THE “COMPA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-09 00:00:008-KStáhnout
2026-02-09 00:00:0010-QStáhnout
2025-11-25 00:00:008-KStáhnout
2025-11-25 00:00:0010-KStáhnout
2025-11-14 00:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-07-03 01:00:008-KStáhnout
2025-07-03 00:00:008-KStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-02-12 00:00:0010-QStáhnout
2025-02-11 23:00:0010-QStáhnout
2024-12-23 00:00:0010-KStáhnout
2024-12-22 23:00:0010-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-07-30 01:00:008-KStáhnout
2024-07-30 00:00:008-KStáhnout
2024-06-21 01:00:008-KStáhnout
2024-06-21 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-02-07 00:00:0010-QStáhnout
2024-02-06 23:00:0010-QStáhnout
2023-11-27 00:00:0010-KStáhnout
2023-11-26 23:00:0010-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-05-24 01:00:008-KStáhnout
2023-05-24 00:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-04-14 01:00:008-KStáhnout
2023-04-14 00:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-02-07 00:00:008-KStáhnout
2023-02-07 00:00:0010-QStáhnout
2023-02-06 23:00:008-KStáhnout
2023-02-06 23:00:0010-QStáhnout
2022-12-02 00:00:008-KStáhnout
2022-12-01 23:00:008-KStáhnout
2022-11-28 00:00:0010-KStáhnout
2022-11-27 23:00:0010-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-05-27 01:00:008-KStáhnout
2022-05-27 00:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-04-08 01:00:008-KStáhnout
2022-04-08 00:00:008-KStáhnout
2022-03-04 00:00:008-KStáhnout
2022-03-03 23:00:008-KStáhnout
2022-02-09 00:00:0010-QStáhnout
2022-02-08 23:00:0010-QStáhnout
2022-02-04 00:00:008-KStáhnout
2022-02-03 23:00:008-KStáhnout
2022-02-02 00:00:008-KStáhnout
2022-02-01 23:00:008-KStáhnout
2021-11-24 00:00:0010-KStáhnout
2021-11-23 23:00:0010-KStáhnout
2021-09-27 01:00:008-KStáhnout
2021-09-27 00:00:008-KStáhnout
2021-09-13 01:00:008-KStáhnout
2021-09-13 00:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-06-24 01:00:008-KStáhnout
2021-06-24 00:00:008-KStáhnout
2021-05-28 01:00:008-KStáhnout
2021-05-28 00:00:008-KStáhnout
2021-05-13 01:00:0010-QStáhnout
2021-05-13 00:00:0010-QStáhnout
2021-02-16 00:00:0010-QStáhnout
2021-02-15 23:00:0010-QStáhnout
2020-12-28 00:00:008-KStáhnout
2020-12-28 00:00:0010-KStáhnout
2020-12-27 23:00:008-KStáhnout
2020-12-27 23:00:0010-KStáhnout
2020-12-15 00:00:008-KStáhnout
2020-12-14 23:00:008-KStáhnout
2020-11-06 00:00:008-KStáhnout
2020-11-05 23:00:008-KStáhnout
2020-10-15 01:00:008-KStáhnout
2020-10-15 00:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-07-02 01:00:008-KStáhnout
2020-07-02 00:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-05-01 01:00:008-KStáhnout
2020-05-01 00:00:008-KStáhnout
2020-04-08 01:00:008-KStáhnout
2020-04-08 00:00:008-KStáhnout
2020-02-06 00:00:0010-QStáhnout
2020-02-05 23:00:0010-QStáhnout
2019-12-16 00:00:0010-KStáhnout
2019-12-15 23:00:0010-KStáhnout
2019-09-13 01:00:008-KStáhnout
2019-09-13 00:00:008-KStáhnout
2019-08-07 01:00:0010-QStáhnout
2019-08-07 00:00:0010-QStáhnout
2019-06-12 01:00:008-KStáhnout
2019-06-12 00:00:008-KStáhnout
2019-05-09 01:00:0010-QStáhnout
2019-05-09 00:00:0010-QStáhnout
2019-04-08 01:00:008-KStáhnout
2019-04-08 00:00:008-KStáhnout
2019-03-18 00:00:008-KStáhnout
2019-03-17 23:00:008-KStáhnout
2019-02-07 00:00:0010-QStáhnout
2019-02-06 23:00:0010-QStáhnout
2018-12-12 00:00:0010-KStáhnout
2018-12-11 23:00:0010-KStáhnout
2018-08-09 01:00:0010-QStáhnout
2018-08-09 00:00:0010-QStáhnout
2018-07-06 01:00:008-KStáhnout
2018-07-06 00:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-04-20 01:00:008-KStáhnout
2018-04-20 00:00:008-KStáhnout
2018-03-08 00:00:008-KStáhnout
2018-03-07 23:00:008-KStáhnout
2018-02-07 00:00:0010-QStáhnout
2018-02-06 23:00:0010-QStáhnout
2017-12-11 00:00:0010-KStáhnout
2017-12-10 23:00:0010-KStáhnout
2017-10-06 01:00:008-KStáhnout
2017-10-06 00:00:008-KStáhnout
2017-08-07 01:00:0010-QStáhnout
2017-08-07 00:00:0010-QStáhnout
2017-05-10 01:00:0010-QStáhnout
2017-05-10 00:00:0010-QStáhnout
2017-04-21 01:00:008-KStáhnout
2017-04-21 00:00:008-KStáhnout
2017-02-13 00:00:008-KStáhnout
2017-02-12 23:00:008-KStáhnout
2017-02-07 00:00:0010-QStáhnout
2017-02-06 23:00:0010-QStáhnout
2016-12-14 00:00:0010-KStáhnout
2016-12-13 23:00:0010-KStáhnout
2016-10-21 01:00:008-KStáhnout
2016-10-21 00:00:008-KStáhnout
2016-08-11 01:00:0010-QStáhnout
2016-08-11 00:00:0010-QStáhnout
2016-07-22 01:00:008-KStáhnout
2016-07-22 00:00:008-KStáhnout
2016-07-07 01:00:008-KStáhnout
2016-07-07 00:00:008-KStáhnout
2016-06-23 01:00:008-KStáhnout
2016-06-23 00:00:008-KStáhnout
2016-05-11 01:00:008-KStáhnout
2016-05-11 01:00:0010-QStáhnout
2016-05-11 00:00:008-KStáhnout
2016-05-11 00:00:0010-QStáhnout
2016-05-06 01:00:008-KStáhnout
2016-05-06 00:00:008-KStáhnout
2016-02-08 00:00:0010-QStáhnout
2016-02-07 23:00:0010-QStáhnout
2015-12-29 00:00:0010-KStáhnout
2015-12-28 23:00:0010-KStáhnout
2015-10-26 00:00:008-KStáhnout
2015-10-25 23:00:008-KStáhnout
2015-10-06 01:00:008-KStáhnout
2015-10-06 00:00:008-KStáhnout
2015-09-28 01:00:008-KStáhnout
2015-09-28 00:00:008-KStáhnout
2015-08-14 01:00:0010-QStáhnout
2015-08-14 00:00:0010-QStáhnout
2015-07-23 01:00:008-KStáhnout
2015-07-23 00:00:008-KStáhnout
2015-06-17 01:00:008-KStáhnout
2015-06-17 00:00:008-KStáhnout
2015-05-29 01:00:008-KStáhnout
2015-05-29 00:00:008-KStáhnout
2015-05-14 01:00:0010-QStáhnout
2015-05-14 00:00:0010-QStáhnout
2015-03-30 01:00:008-KStáhnout
2015-03-30 00:00:008-KStáhnout
2015-02-17 00:00:0010-QStáhnout
2015-02-16 23:00:0010-QStáhnout
2014-12-29 00:00:0010-KStáhnout
2014-12-28 23:00:0010-KStáhnout
2014-12-12 00:00:008-KStáhnout
2014-12-11 23:00:008-KStáhnout
2014-10-23 01:00:008-KStáhnout
2014-10-23 00:00:008-KStáhnout
2014-08-25 01:00:008-KStáhnout
2014-08-25 00:00:008-KStáhnout
2014-08-13 01:00:0010-QStáhnout
2014-08-13 00:00:0010-QStáhnout
2014-05-14 01:00:008-KStáhnout
2014-05-14 01:00:0010-QStáhnout
2014-05-14 00:00:008-KStáhnout
2014-05-14 00:00:0010-QStáhnout
2014-03-19 00:00:008-KStáhnout
2014-03-18 23:00:008-KStáhnout
2014-03-14 00:00:008-KStáhnout
2014-03-13 23:00:008-KStáhnout
2014-02-24 00:00:008-KStáhnout
2014-02-23 23:00:008-KStáhnout
2014-02-14 00:00:0010-QStáhnout
2014-02-13 23:00:0010-QStáhnout
2014-02-10 00:00:008-KStáhnout
2014-02-09 23:00:008-KStáhnout
2013-12-30 00:00:0010-KStáhnout
2013-12-29 23:00:0010-KStáhnout
2013-11-15 00:00:008-KStáhnout
2013-11-14 23:00:008-KStáhnout
2013-11-12 00:00:008-KStáhnout
2013-11-11 23:00:008-KStáhnout
2013-08-14 01:00:0010-QStáhnout
2013-08-14 00:00:0010-QStáhnout
2013-07-08 01:00:008-KStáhnout
2013-07-08 00:00:008-KStáhnout
2013-05-17 01:00:0010-QStáhnout
2013-05-17 00:00:0010-QStáhnout
2013-02-14 00:00:0010-QStáhnout
2013-02-13 23:00:0010-QStáhnout
2013-01-10 00:00:008-KStáhnout
2013-01-09 23:00:008-KStáhnout
2012-12-31 00:00:0010-KStáhnout
2012-12-30 23:00:0010-KStáhnout
2012-08-17 01:00:0010-QStáhnout
2012-08-17 00:00:0010-QStáhnout
2012-06-28 01:00:008-KStáhnout
2012-06-28 00:00:008-KStáhnout
2012-06-07 01:00:008-KStáhnout
2012-06-07 00:00:008-KStáhnout
2012-05-15 01:00:0010-QStáhnout
2012-05-15 00:00:0010-QStáhnout
2012-03-28 01:00:008-KStáhnout
2012-03-28 00:00:008-KStáhnout
2012-02-14 00:00:0010-QStáhnout
2012-02-13 23:00:0010-QStáhnout
2012-02-13 00:00:008-KStáhnout
2012-02-12 23:00:008-KStáhnout
2011-12-22 00:00:0010-KStáhnout
2011-12-21 23:00:0010-KStáhnout
2011-12-08 00:00:008-KStáhnout
2011-12-07 23:00:008-KStáhnout
2011-11-16 00:00:008-KStáhnout
2011-11-15 23:00:008-KStáhnout
2011-10-21 01:00:008-KStáhnout
2011-10-21 00:00:008-KStáhnout
2011-10-14 01:00:008-KStáhnout
2011-10-14 00:00:008-KStáhnout
2011-09-21 01:00:008-KStáhnout
2011-09-21 00:00:008-KStáhnout
2011-08-12 01:00:0010-QStáhnout
2011-08-12 00:00:0010-QStáhnout
2011-08-03 01:00:008-KStáhnout
2011-08-03 00:00:008-KStáhnout
2011-06-09 01:00:008-KStáhnout
2011-06-09 00:00:008-KStáhnout
2011-05-16 01:00:008-KStáhnout
2011-05-16 01:00:0010-QStáhnout
2011-05-16 00:00:008-KStáhnout
2011-05-16 00:00:0010-QStáhnout
2011-05-09 01:00:008-KStáhnout
2011-05-09 00:00:008-KStáhnout
2011-04-26 01:00:008-KStáhnout
2011-04-26 00:00:008-KStáhnout
2011-04-18 01:00:008-KStáhnout
2011-04-18 00:00:008-KStáhnout
2011-04-13 01:00:008-KStáhnout
2011-04-13 00:00:008-KStáhnout
2011-03-23 00:00:008-KStáhnout
2011-03-22 23:00:008-KStáhnout
2011-02-28 00:00:008-KStáhnout
2011-02-27 23:00:008-KStáhnout
2011-02-22 00:00:008-KStáhnout
2011-02-21 23:00:008-KStáhnout
2011-02-14 00:00:0010-QStáhnout
2011-02-13 23:00:0010-QStáhnout
2011-02-08 00:00:008-KStáhnout
2011-02-07 23:00:008-KStáhnout
2011-02-07 00:00:008-KStáhnout
2011-02-06 23:00:008-KStáhnout
2010-12-27 00:00:0010-KStáhnout
2010-12-26 23:00:0010-KStáhnout
2010-11-30 00:00:008-KStáhnout
2010-11-29 23:00:008-KStáhnout
2010-11-22 00:00:008-KStáhnout
2010-11-21 23:00:008-KStáhnout
2010-09-27 01:00:008-KStáhnout
2010-09-27 00:00:008-KStáhnout
2010-09-09 01:00:008-KStáhnout
2010-09-09 00:00:008-KStáhnout
2010-08-20 01:00:0010-QStáhnout
2010-08-20 00:00:0010-QStáhnout
2010-08-18 01:00:008-KStáhnout
2010-08-18 00:00:008-KStáhnout
2010-07-09 01:00:008-KStáhnout
2010-07-09 00:00:008-KStáhnout
2010-07-06 01:00:008-KStáhnout
2010-07-06 00:00:008-KStáhnout
2010-05-21 01:00:0010-QStáhnout
2010-05-21 00:00:0010-QStáhnout
2010-05-04 01:00:008-KStáhnout
2010-05-04 00:00:008-KStáhnout
2010-04-12 01:00:008-KStáhnout
2010-04-12 00:00:008-KStáhnout
2010-02-22 00:00:0010-QStáhnout
2010-02-21 23:00:0010-QStáhnout
2009-12-24 00:00:0010-KStáhnout
2009-12-23 23:00:0010-KStáhnout
2009-11-24 00:00:008-KStáhnout
2009-11-23 23:00:008-KStáhnout
2009-08-19 01:00:0010-QStáhnout
2009-08-19 00:00:0010-QStáhnout
2009-08-12 01:00:008-KStáhnout
2009-08-12 00:00:008-KStáhnout
2009-06-26 01:00:008-KStáhnout
2009-06-26 00:00:008-KStáhnout
2009-06-23 01:00:008-KStáhnout
2009-06-23 00:00:008-KStáhnout
2009-05-20 01:00:0010-QStáhnout
2009-05-20 00:00:0010-QStáhnout
2009-04-03 01:00:008-KStáhnout
2009-04-03 00:00:008-KStáhnout
2009-02-23 00:00:0010-QStáhnout
2009-02-22 23:00:0010-QStáhnout
2009-01-13 00:00:0010-KStáhnout
2009-01-12 23:00:0010-KStáhnout
2008-06-05 01:00:008-KStáhnout
2008-06-05 00:00:008-KStáhnout
2008-05-23 01:00:008-KStáhnout
2008-05-23 00:00:008-KStáhnout
2008-03-04 00:00:008-KStáhnout
2008-03-03 23:00:008-KStáhnout
2007-12-21 00:00:008-KStáhnout
2007-12-20 23:00:008-KStáhnout
2007-09-28 01:00:008-KStáhnout
2007-09-28 00:00:008-KStáhnout
2007-09-27 01:00:008-KStáhnout
2007-09-27 00:00:008-KStáhnout
2007-02-22 00:00:008-KStáhnout
2007-02-21 23:00:008-KStáhnout
2007-02-09 00:00:008-KStáhnout
2007-02-08 23:00:008-KStáhnout
2007-02-07 00:00:008-KStáhnout
2007-02-06 23:00:008-KStáhnout
2007-02-01 00:00:008-KStáhnout
2007-01-31 23:00:008-KStáhnout
2007-01-25 00:00:008-KStáhnout
2007-01-24 23:00:008-KStáhnout
2006-06-09 01:00:008-KStáhnout
2006-06-09 00:00:008-KStáhnout
2006-05-30 01:00:008-KStáhnout
2006-05-30 00:00:008-KStáhnout
2006-05-15 01:00:0010-QStáhnout
2006-05-15 00:00:0010-QStáhnout
2006-04-27 01:00:008-KStáhnout
2006-04-27 00:00:008-KStáhnout
preloader